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INTRODUCTION
NC/Nga (NC) mice have been shown to develop
human atopic-like skin lesions with elevated se-
rum IgE level when kept in conventional conditions
(1, 2). NC mice have been used as model animals
for evaluating the effects of anti-inflammatory drugs
and food-derived components on the development
of atopic dermatitis. In addition to allergic response,
NC mice have been shown to possess unique im-
munological phenotypes, including a defect in toll-
like receptor 9-mediated activation, deletion poly-
morphysm of the FcγIIB gene promoter region,
and a defect in oral tolerance (3-5). In this study,
we found that NC mice have and impaired antigen
(Ag)-specific T cell response after ovalbumin (OVA)
immunization. Therefore, we focused on the func-
tion of antigen (Ag)-presenting cells in NC mice
MATERIALS AND METHODS
Mice and immunization
Specific pathogen-free female NC (H-2d) (6) ,
BALB/c (H-2d) and DBA/2 (H-2d) mice were pur-
chased from SLC (Hamamatsu, Japan). DO11.10
mice were purchased from Jackson Lab. (Bar
Harbor, ME, USA). All studies were performed in
accordance with the ethical guidelines for animal
experimentation by the Institution of Health Bi-
oscience, the University of Tokushima and were ap-
proved by the institutional review board of the ani-
mal ethics committee.
Mice were intraperitoneally immunized with 10 μg
of OVA (Sigma Chemical Co., MO, USA) absorbed
in 1 mg of Aluminium Hydroxide Gel Adjuvant (HCI
Biosector, Denmark) 2 times at a 2-week interval.
ORIGINAL
Decreased expression of MHC class II and cathepsin E in
dendritic cells might contribute to impaired induction
of antigen-specific T cell response in NC/Nga mice
Tohru Sakai, Emi Shuto, Tomoyo Taki, Honami Imamura, Miku Kioka,
Akiko Nakamoto, Seiji Mizoguchi, Shouko Amano, Yukari Kawano,
Mariko Nakamoto, Rie Tsutumi, and Toshio Hosaka
Department of Public Health and Applied Nutrition, Institution of Health Bioscience, the University
of Tokushima Graduate School, Tokushima, Japan
Abstract : NC/Nga (NC) mice are an animal model for human atopic dermatitis. We found
that induction of antigen (Ag)-specific T cell response is diminished in ovalbumin (OVA)-
immunized NC mice. Ability of Ag presentation in NC mouse dendritic cells (DCs) was sig-
nificantly weaker than that in BALB/c and DBA/2 mouse DCs. Expression levels of MHC
class II molecules and cathepsin E in NC mouse DCs were significantly lower that those
in BALB/c and DBA/2 mouse DCs. These results indicate that low expression levels of MHC
class II and cathepsin E might contribute to the defect in induction of Ag-specific T cells
in NCmice. J. Med. Invest. 59 : 95-101, February, 2012
Keywords : cathepsin E, dendritic cells, MHC class II, NC/Nga mice
Received for publication October 28, 2011 ; accepted November
21, 2011.
Address correspondence and reprint requests to Tohru Sakai,
Department of Public Health and Applied Nutrition, Institution of
Health Bioscience, the University of Tokushima Graduate School,
Kuramoto-cho, Tokushima 770-8503, Japan and Fax : +81-88-
633-9427.
The Journal of Medical Investigation Vol. 59 2012
95
Proliferation assay
Splenocytes from OVA- immunized mice were
cultured in the medium supplemented with 10% fe-
tal bovine serum, 50 μmol/L 2-mercaptoethanol,
100 μg/mL streptomycin, and 100 U/mL penicillin.
Five105 splenocytes were stimulated with 200 μg/
mL OVA, 1,000 μg/mL OVA or with plate-bound
anti-CD3 mAb (coated overnight at 1 μg/mL) in a
96-well flat-bottom plate at 37under 5% CO2 for
72 h. For the last 8 h of culture, 1 μCi of [3H]
thymidine deoxyribose (TdR) was added to the
wells, and the amount of [3H]TdR incorporated was
measured by a scintillation counter (Aloka, Tokyo,
Japan).
Ag-presenting ability
CD11c+ cells were purified from 3 to 4 mice us-
ing CD11c microbeads and a MACS LS column
(Miltenyi Biotec Inc., CA, USA) according to the
manufacturer’s instructions. CD4+ T cells were pu-
rified from DO11.10 transgenic mice, which express
OVA-specific T cell receptor, using a CD4+ T cell
isolation kit (Miltenyi Biotec). CD4+ T cells (2105
cells) from a DO11.10 mouse spleen were cultured
in a 96-well plate with CD11 c+ cells (104 cells) in
the presence of 200 μg/ml OVA for 48 hr at 37/
5% CO2. Cultures were pulsed with 1 μCi of [3H]TdR
for the last 8 hr of culture. Incorporated [3H]TdR
was determined by a scintillation counter.
Flow cytometry
Expression of MHC class I, MHC class II and
CD80 molecules was analyzed by flow cytometric
analysis. Purified CD11c+ cells were incubated with
FITC-conjugated anti-mouse H-2Kd mAb (clone SF1-
1.1), PE-conjugated anti-mouse I-A mAb (clone
M5/114/15.2) or FITC-conjugated anti-CD80 mAb
(clone 16-10A1) or 30 min at 4. After washing the
cells, stained cells were analyzed with a FACSCalibur
and CellQuest software (Becton Dickinson, CA,
USA).
Quantitative PCR analysis
To assess gene expressions, mRNA levels of
genes involved in MHC class II expression were de-
termined by reverse transcription of total RNA fol-
lowed by PCR analysis. Total RNA was isolated from
CD11c+ cells using a RNeasy Micro kit (Qiagen
Science, MD, USA). First-strand cDNA was reverse-
transcribed at 42for 60 min and at 95for 5 min
from 2 μg of the extracted total RNA with M-MLV
reverse transcriptase (Invitrogen, CA, USA) and a
random primer. We performed real-time PCR us-
ing specific primers and SYBR green dye (Takara
Bio, Japan) in a Light Cycler real-time PCR system
(Roche Diagnostics, Germany) according to the
manufacturer’s instructions. The primers used were
5’ -CAGATACCATCAACTGCGACCA-3’ (sence)
and 5’ -TCTGCTCCAATGTGCTCTATGAAG-3’ (an-
tisense) for CTIIT, 5’ -AGTCAGTGGAGGCCAGC-
TTA-3’ (sense) and 5’ -CCAGGAGGCACCAACTG-
TAT-3’ (antisence) for NF-Yα, 5’-GCTGACGCTG-
GAGAACCTAC-3’ (sense) and 5’ -CGATGGGAG-
CTGAAGGTAGA-3’ (antisense) for RFX5, 5’ -CAC-
AGACGGCGTTTATGAGA-3’ (sense) and 5’ -TGC-
TCCACCTTGCAGTCATA-3 (antisense) for H-2d, 5’-
CTGACCCTGAAGTACCCCATTGAACA-3’ (sense)
and 5’ -CTGGGGTGTTGAAGGTCTCAAACATG-3
(antisense) for β -actin’. The relative abundance of
target transcripts was normalized to the constitutive
expression of β -actin.
Western blot analysis
CD11c+ cells were lysed in lysis buffer containing
1% Noidet-P40, 150 mM NaCl, 10 mM Tris-Cl (pH
7.5), and 1 mM EDTA. The cell lysates were disso-
loved by SDS-PAGE and transferred onto a PVDF
membrane. The membrane was blotted with an Ab
to cathepsin S (Santa Cruz, CA, USA), cathepsin E
(Novas Biologicals, CO, USA) or β -actin (Epitomics,
Inc., CA, USA) and visualized using an enhanced
chemiluminescence system (Amersham Biosciences,
UK). Quantification of protein expression was per-
formed by densitometry analysis of the autoradio-
grams.
Statistical analysis
Data were analyzed using one-way analysis of
variance followed by the Scheffe post hoc test for
multiple comparisons. Values in the text are means
SD. Differences were considered significant at P
0.05.
RESULTS
Decreased Ag-specific T cell response in OVA-
immunized NC mice
OVA-specific proliferation response after OVA im-
munization in NC mice was significantly decreased
compared to that in BALB/c and DBA/2 mice.
However, proliferation response to anti-CD3 mA in
NC mice was comparable to that in BALB/c and
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DBA/2 mice (Fig. 1), suggesting that T cell recep-
tor-mediated signal transduction is normal in NC
mice. This finding indicates the possibility that weak
induction of Ag-specific T cells in NC mice contrib-
utes to the process of Ag-specific T cell induction.
Characterization of CD11c+ dendritic cells (DCs)
from NC mice
We next examined CD11c+ cell function because
DCs are known to be a crucial cell population for in-
itiation of acquired immune responses. Ag-present-
ing ability of DCs was evaluated by using DO11.10
CD4+ cells that carried the OVA-specific T cell re-
ceptor gene. In the Ag presentation process toward
to MHC class II, at first Ag-presenting cells capture
Ag, digest the captured Ag in the lysosome, and
then present Ag-derived peptide/MHC class II com-
plex on the cell surface. In the case of intact OVA
stimulation, proliferation response of DO11.10 CD4+
cells when co-cultured with NC mouse CD11c+ cells
was significantly decreased compared to that when
co-cultured with BALB/c or DBA/2 mouse CD11c+
cells (Fig. 2). We evaluated the ability of Ag-inter-
nalization in NC mouse CD11c+ cells using FITC-
labeled OVA, but a significant difference was not ob-
served compared to that in BALB/c mouse CD11c+
cells (data not shown). Next, cell surface expres-
sions of MHC class I, MHC class II, and CD80 were
Fig. 1. OVA-specific T cell responses in BALB/c, DBA/2 and NC mice. Mice were immunized with OVA 2 times at a 2-week-
interval. Two weeks after the second immunization, spleen cells were stimulated with OVA or anti -CD3 mAb for 72 hr in vitro . Pro-
liferation response was determined by counting incorporated [3H]TdR activity. Results are expressed as meansSD. White, black
and hatched bars indicate BALB/c, DBA/2 and NC mice, respectively. Data are presented as meansSD. **P0.01.
Fig. 2. Characterization of NC mouse DCs. DO11.10 CD4+ cells were stimulated with OVA in the presence of indicated number of
DCs from BALB/c, DBA/2 or NC mice. Ag-presenting ability of DCs was evaluated by incorporated [3H]TdR activity. Levels of in-
corporated [3H]TdR were less than 1,500 cpm when DO11.10 CD4+ cells or DCs alone were cultured with OVA. Levels of incorporated
[3H]TdR were less than 500 cpm when DO11.10 CD4+ cells or DCs alone were cultured with medium only. Results are expressed as
meansSD. The data are representative of two independent experiments of pooled samples from 3 or 4 mice.
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determined by flow cytometric analysis. Expression
level of MHC class II in NC mouse CD11c+ cells
was significantly lower that that in BALB/c mouse
CD11c+ cells. Reduced MHC class II expression was
observed not only in DCs but also in B cells in NC
mice (data not shown). In the case of MHC class I
and CD80, expression of these molecules in NC
mouse DCs was slightly lower than that in BALB/c
and DBA/2 mouse DCs (Fig. 3). Although we also
evaluated transcription factors that contribute to
MHC class II expression, differences in the expres-
sion of CIITA, NF-Yα and RFX5 were not observed
between NC, BALB/c and DBA/2 mice (Fig.4 B-
D).
Fig. 3. Expression of MHC class I, MHC class II and CD80 in DCs from BALB/c, DBA/2 and NC mice. Expression of MHC class
II was determined as described in the “Materials and methods” section. Shaded histograms represent cells stained with an isotype-
matched control Ab.
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Decreased expression of cathepsin E in NC mouse
CD11c+ DCs
Cathepsin S is a member of the papain family of
cystein proteases (7), and cathepsin E is an intra-
cellular aspartic protease of the pepsin superfamily
(8). Both molecules have been shown to be crucial
for Ag processing and presentation in Ag-presenting
cells (9). Expression of cathepsin S and cathepsin
E in DCs was determined by Western blot analysis.
A difference in cathepsin S expression was not ob-
served between BALB/c, DBA/2 and NC mouse
CD11c+ cells. In contrast, it was found that expres-
sion of cathepsin E in NC mouse DCs was signifi-
cantly decreased compared to that in BALB/c and
DBA/2 mouse DCs (Fig. 5). Densitometry analysis
Fig. 4. CIITA, NF-Yα and RFX5 mRNA expression levels in DCs. cDNA was prepared from purified CD11c+ cells and analyzed for
expression of CIITA (A), NF-Yα (B), RFX5 (C) and β -actin message by quantitative RCR as described in the “Materials and methods”
section. Data are presented as meansSD. **P0.01.
Fig. 5. Expression of cathepsin E and S in DCs. (A) Expression of cathepsin E and cathepsin S was analyzed by Western blotting
with anti -cathepsin E and anti -cathepsin S mAb. To ensure the presence of equal amounts of protein, the membranes were re-
probed with an anti -β -actin mAb. (B) Histograms show the cathepsin E/β -actin and cathepsin S/β -actin ratio. Data are presented
as meansSD. *P0.05.
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of autoradiograms showed that the relative expres-
sion level of cathepsin E in NC mice is one-tenth
of that in BALB/c and DBA/2 mice.
DISCUSSION
NC mice provide a new animal model for the
study of atopic-like dermatitis and allergy disease.
The contribution of possible immunological factors
to the development of allergic response in NC mice
has been revealed (6, 10-12). In addition to the de-
velopment of allergic response, it has been shown
that NC mice posses unique immunologic pheno-
types [3-5]. In the course of investigating the mecha-
nism for the onset of allergic response in NC mice,
we found that Ag-specific T cell response following
Ag immunization was severely impaired (Fig. 1).
To elucidate the mechanism for this phenotype, we
focused on DC function in NC mice. Consistent
with the impaired induction of Ag-specific T cells,
Ag-presenting ability in NC mice was significantly
weaker than that in BALB/c and DBA/2 mice
(Fig. 2). Furthermore, expression level of MHC
class II in NC mouse DCs was about half of that in
BALB/c mouse DCs (Fig. 3). The main control ele-
ment regulating transcription is a highly conserved
150-bp promoter proximal region situated upstream
of the transcription initiation site. Additional pro-
moter distal regulatory elements have been identi-
fied (13). At first, we examined the nucleotide se-
quence in conserved regulatory elements, named
distal Y’ -S’ motif and proximal S-Y motifs, between
NC and BALB/c mice, but a difference was not
found. In addition, expression of DNA-binding pro-
teins, CIITA, RFX and NF-Y, were examined by
real-time PCR assay and no differences in expres-
sion levels were found (Fig.4 B-D).
Several lines of evidence suggest that cathepsin E
plays a role in Ag processing via the MHC class II
pathway (14). Treatment with a cathepsin E-specific
inhibitor inhibits Ag processing, resulting in an im-
paired Ag-specific T cell response. Similar to the re-
sults obtained by using a specific inhibitor, cathepsin
E-deficient mouse DCs showed reduced ability of
antigen presentation. Cathepsin E is mainly present
in the endosome compartment in DCs. In this study,
we found that expression of cathepsin E, but not that
of cathepsin S, in NC mouse DCs was weak. Re-
duced Ag presenting ability of exogenous Ag in NC
mouse DCs was similar to that in cathepsin E-defi-
cient mouse DCs or DCs treated with a cathepsin
E-specific inhibitor. From these findings, it seems
likely that a low level of cathepsin E expression con-
tributes to defect in Ag-presenting ability in NC
mice. However, it is not known whether a low level
of cathepsin E expression directly affects the expres-
sion of MHC class II because expression of MHC
class II in cathepsin E-deficient mouse DCs was
comparable to that in wild - type mice (15). We
speculate that decreased expression of MHC class
II and cathepsin E synergistically affect Ag-present-
ing ability in DCs, resulting in impaired induction of
Ag-specific T cell response in NC mice.
NC mice have been shown to develop human
atopic-like skin (1, 2). Interestingly, cathepsin E-de-
ficient mice develop atopic-like dermatitis. Tsukuba
et al. showed that development of atopic dermati-
tis in cathepsin E-deficient mice contributes to the
systemic accumulation of IL-18 and IL-1β. They
also showed cathepsin E activity in erythrocyte
ghosts in NC mice and found that cathepsin E ac-
tivity in NC mice was lower than that in C57BL/6
mice (16).
In this study, we found a new immunologic phe-
notype in NC mice. Low MHC class II and cathep-
sin E expression levels in an experimental animal
have not previously been reported. Therefore, NC
mice will provide a new useful animal model for
investigation of induction of Ag-specific immune
response and acquired immunity.
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